Skip to content
Home/Companies/Biotech/ALLOX
ALLOX

ALLOX

Biotech·Spain·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns ALLOX?

ALLOX is currently owned by Asabys Partners through Sabadell Asabys Health Innovation Investments II (2023 vintage), since 2023.

Hand-verified · updated 2026-08-09

Asabys Partners
Investor
Asabys Partners
Sabadell Asabys Health Innovation Investments II · 2023 · Life Sciences VC

Key facts

HQSpain
SectorBiotech
StatusActive
Websitewww.allox.bio

More from Sabadell Asabys Health Innovation Investments II

Other portfolio companies in the same fund.

Oriva Therapeutics
Active
BiotechSpain· 2026
Quibim
Active
HealthTechSpain· 2025
SafeHeal
SafeHeal
Active
MedTechFrance· 2025
Augustine Therapeutics
Augustine Therapeutics
Active
BiotechBelgium· 2024
Deepull
Active
MedTechSpain· 2023
Gradient Denervation Technologies
Gradient Denervation Technologies
Active
MedTechFrance· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Allox

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Allox.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue